The mainstream media has embraced palbociclib, a new breast cancer drug that may work against a number of other cancers, too.  Early reports broke on business websites.  This is to be expected.  After all, hope helps stock soar.

When I want the real story, I turn to New York Times medical writer, Andrew Pollack.  Here’s an excerpt from his report on Sunday:

Guarded Optimism After Breast Cancer Drug Shows Promising Results

Leave a Reply